TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?

Neuro Oncol. 2024 May 3;26(5):840-842. doi: 10.1093/neuonc/noae019.

Authors

Sourav Ghosh¹, Carla V Rothlin²

Affiliations

¹ Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
² Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 38290471
PMCID: PMC11066908 (available on 2025-01-30)
DOI: 10.1093/neuonc/noae019

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Editorial
Comment

MeSH terms

Brain Neoplasms* / immunology
Brain Neoplasms* / metabolism
Brain Neoplasms* / pathology
Glioblastoma* / immunology
Glioblastoma* / metabolism
Glioblastoma* / pathology
Humans
Membrane Glycoproteins* / immunology
Membrane Glycoproteins* / metabolism
Receptors, Immunologic* / immunology
Receptors, Immunologic* / metabolism
Tumor Microenvironment* / immunology

Substances

Receptors, Immunologic
TREM2 protein, human
Membrane Glycoproteins